WT1 gene analysis in sporadic early-onset and bilateral Wilms tumor patients without associated abnormalities

Journal of Pediatric Hematology/Oncology

Volumn 27, Issue 4, 2005, Pages 197-201

  Perotti, Daniela ^a   Mondini, Patrizia ^a   Terenziani, Monica ^a   Spreafico, Filippo ^a   Collini, Paola ^a   Fossati Bellani, Franca ^a   Radice, Paolo ^a,b  

^a NATIONAL CANCER INSTITUTE   (Italy)

^b FIRC INSTITUTE OF MOLECULAR ONCOLOGY   (Italy)

Author keywords

Genetic predisposition; Germline mutations; Wilms tumor; WT1

Indexed keywords

CANCER SURVIVAL; CANCER SUSCEPTIBILITY; CLINICAL ARTICLE; CONFERENCE PAPER; CONGENITAL DISORDER; CONTROLLED STUDY; DENYS DRASH SYNDROME; EXON; FEMALE; GENE; GENE MUTATION; GENETIC ANALYSIS; GENETIC PREDISPOSITION; HETEROZYGOSITY LOSS; HOMOZYGOSITY; HUMAN; HUMAN CELL; INFANT; MALE; NEPHROBLASTOMA; ONSET AGE; PRESCHOOL CHILD; PRIORITY JOURNAL; RISK FACTOR; SOUTHERN BLOTTING; SURVIVAL RATE; WAGR SYNDROME; WT1 GENE;

AGE OF ONSET; CHILD; CHILD, PRESCHOOL; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GERM-LINE MUTATION; HUMANS; INFANT; KIDNEY NEOPLASMS; LOSS OF HETEROZYGOSITY; MALE; WILMS TUMOR; WT1 PROTEINS;

EID: 18044394015     PISSN: 10774114     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mph.0000161270.22313.2f     Document Type: Conference Paper

References (41)

1. Green DM, Coppes MJ, Breslow NE, et al. Wilms tumor. In: Pizzo PA, Poplack DG, eds. Principles and Practice of Pediatric Oncology, Philadelphia: Lippincott-Raven, 1997:733-759.
2. Wiedemann HR. Familial malformation complex with umbilical hernia and macroglossia: a new syndrome? J Genet Hum. 1964;13:223-232.
3. Beckwith JB. Macroglossia, omphalocele, adrenal cytomegaly, gigantism and hyperplastic visceromegaly. Birth Defects Original Articles Series V. 1969;188-196.
4. Francke U, Holmes LB, Atkins L, et al. Aniridia-Wilms tumor association: evidence for specific deletion of 11p13. Cytogenet Cell Genet. 1979;24:185-192.
5. Denys P. Malvaux P, Van Den Berghe H, et al. Association d'un syndrome anatomo-pathologique de pseudohermaphrodisme masculin, d'une tumeur de Wilms, d'une nephropathie parenchymateuse et d'un mosaicisme XX/XY. Arch Fr Pediatr. 1967;24:729-739.
6. Drash A, Sherman F, Hartmann WH, et al. A syndrome of pseudohermaphroditism, Wilms' tumor, hypertension, and degenerative renal disease. J Pediatr. 1970;76:585-593.
7. Koufos A, Grundy P, Morgan K, et al. Familial Wiedemann-Beckwith syndrome and a second Wilms tumor locus both map to 11p15.5. Am J Hum Genet. 1989;44:711-719.
8. Ping AJ, Reeve AE, Law DJ, et al. Genetic linkage of Beckwith-Wiedemann syndrome to 11p15. Am J Hum Genet. 1989;44:720-723.
9. Call KM, Glaser T, Ito CY, et al. Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms tumor locus. Cell 1990;60:509-520.
10. Bonetta L, Kuehn SE, Huang A, et al. Wilms tumor locus on 11p13 defined by multiple CpG island-associated transcripts. Science. 1990;250:994-997.
11. Gessler M, Poustka A, Cavenee W, et al. Homozygous deletion in Wilms tumours of a zinc-finger gene identified by chromosome jumping. Nature. 1990;343:774-778.
12. Rauscher FJ III. The WT1 Wilms tumor gene product: a developmentally regulated transcription factor in the kidney that functions as a tumor suppressor. FASEB J. 1993;7:896-903.
13. Hastie ND. The genetics of Wilms tumor: a case of disrupted development. Annu Rev Genet. 1994;28:523-558.
14. Haber DA, Sohn RL, Buckler AJ, et al. Alternative splicing and genomic structure of the Wilms tumor gene WT1. Proc Natl Acad Sci USA. 1991;88:9618-9622.
15. Bickmore WA, Oghene K, Little MH, et al. Modulation of DNA binding specificity by alternative splicing of the Wilms tumor WT1 gene transcript. Science. 1992;257:235-237.
16. Caricasole A, Duarte A, Larsson SH, et al. RNA binding by the Wilms tumor suppressor zinc finger proteins. Proc Natl Acad Sci USA. 1996;93:7562-7566.
17. Little M, Wells C. A clinical overview of WT1 gene mutations. Hum Mutat. 1997;9:209-225.
18. Coppes MJ, Liefers GJ, Paul P. et al. Homozygous somatic WT1 point mutations in sporadic unilateral Wilms tumor. Proc Natl Acad Sci USA. 1993;90:1416-1419.
19. Schumacher V, Schneider S, Figge A, et al. Correlation of germ-line mutations and two-hit inactivation of the WT1 gene with Wilms tumors of stromal-predominant histology. Proc Natl Acad Sci USA. 1997;94:3972-3977.
20. Diller L, Ghahremani M, Morgan J, et al. Constitutional WT1 mutations in Wilms tumor patients. J Clin Oncol. 1998;16:3634-3640.
21. Huff V. Wilms tumor genetics. Am J Med Genet. 1998;79:260-267.
22. Nakadate H, Yokomori K, Watanabe N, et al. Mutations/deletions of the WT1 gene, loss of heterozygosity on chromosome arms 11p and 11q, chromosome ploidy and histology in Wilms tumors in Japan. Int J Cancer. 2001;94:396-400.
23. Little SE, Hanks SP, King-Underwood L, et al. Frequency and heritability of WT1 mutations in nonsyndromic Wilms tumor patients: a UK Children's Cancer Study Group Study. J Clin Oncol. 2004;22:4140-4146.
24. Reddy JR, Licht JD. The WT 1 Wilms tumor suppressor gene: how much do we really know? Biochim Biophys Acta. 1996;1287:1-28.
25. Grundy P, Telzerow P, Moksness J, et al. Clinicopathologic correlates of loss of heterozygosity in Wilms tumor, a preliminary analysis. Med Pediatr Oncol. 1996;27:429-433.
26. Royer-Pokora B, Beier M, Henzler M, et al. Twenty-four new cases of WT1 germline mutations and review of the literature: genotype/phenotype correlations for Wilms tumor development. Am J Med Genet. 2004;127A: 249-257.
27. Radice P, Pilotti S, De Benedetti V et al. Homozygous intragenic loss of the WT1 locus in a sporadic intralobar Wilms tumor. Int J Cancer. 1993;55:174-176.
28. Perotti D, Mondini P, Giardini R, et al. No evidence of WT1 involvement in Burkitt's lymphoma in a patient with Denys-Drash syndrome. Ann Oncol. 1998;9:627-631.
29. Radice P, Perotti D, De Benedetti V, et al. Allelotyping in Wilms tumors identifies a putative third tumor suppressor gene on chromosome 11. Genomics. 1995;27:497-501.
30. Pritchard-Jones K, Fleming S, Davidson D, et al. The candidate Wilms tumour gene is involved in genitourinary development. Nature. 1990;346:194-197.
31. Armstrong JF, Pritchard-Jones K, Bickmore WA, et al. The expression of the Wilms tumour gene, WT1, in the developing mammalian embryo. Mech Dev. 1992;40:85-97.
32. Kreidberg JA, Sariola H, Loring JM, et al. WT1 is required for early kidney development. Cell. 1993;74:679-691.
33. Pelletier J, Bruening W, Li FP, et al. WT1 mutations contribute to abnormal genital system development and hereditary Wilms tumour. Nature. 1991;353:431-434.
34. Pelletier J, Bruening W, Kashtan CE, et al. Germline mutations in the Wilms tumor suppressor gene are associated with abnormal urogenital development in Denys-Drash syndrome. Cell. 1991;67:437-447.
35. Little MH, Williamson KA, Mannens M, et al. Evidence that WT1 mutations in Denys-Drash syndrome patients may act in a dominant-negative fashion. Hum Mol Genet. 1993;2:259-264.
36. Pritchard-Jones K. Controversies and advances in the management of Wilms tumour. Arch Dis Child. 2002;87:241-244.
37. Coppes MJ, Liefers GJ, Higuchi M, et al. Inherited WT1 mutation in Denys-Drash syndrome. Cancer Res. 1992;52:6125-6128.
38. Kaplinsky C, Ghahremani M, Frishberg Y, et al. Familial Wilms tumor associated with a WT1 zinc finger mutation. Genomics. 1996;38:451-453.
39. Pritchard-Jones K, Rahman N, Gerrard M, et al. Familial Wilms tumour resulting from WT1 mutation: intronic polymorphism causing artefactual constitutional homozygosity. J Med Genet. 2000;37:377-379.
40. Schumacher V, Schuhen S, Sonner S, et al. Two molecular subgroups of Wilms tumors with or without WT1 mutations. Clin Cancer Res. 2003;9:2005-2014.
41. Pierotti MA, Radice P, Biunno I, et al. Detection of two TaqI polymorphisms in the VTR region of human HRAS1 oncogene. Cytogenet Cell Genet. 1986;43:174-180.